Piramal Pharma Ltd. Share Price Target
Here are the projected share price target for Piramal Pharma Ltd. for 2025, 2026, 2027, 2028, 2029, 2030, 2040, to 2050 based on various analyses.
| Year | Target 1 | Target 2 |
|---|---|---|
| 2025 | ₹323 | ₹353 |
| 2026 | ₹437 | ₹487 |
| 2027 | ₹551 | ₹601 |
| 2028 | ₹665 | ₹715 |
| 2029 | ₹779 | ₹829 |
| 2030 | ₹894 | ₹964 |
| 2040 | ₹1788 | ₹1928 |
| 2050 | ₹2356 | ₹3856 |
Piramal Pharma Ltd. Share Price Target 2025 : Analysts predict potential Targets of ₹323, ₹353 by the end of 2024. The stop loss levels are set at ₹290.7, ₹317.7.
Piramal Pharma Ltd. Share Price Target 2026 : Projections for 2026 suggests a minimum Target of ₹437 and a maximum of ₹487.
Piramal Pharma Ltd. Share Price Target 2027 : The price target range from ₹551 to ₹601 depending on market conditions.
Piramal Pharma Ltd. Share Price Target 2028 : At the start of 2028, the price is projected to be around ₹665 and by the end of the 2028, the price target is expected to reach approximately ₹715.
Piramal Pharma Ltd. Share Price Target 2029 : The share price is expected to start the year around ₹779 and by the end of the year, the share price might reach approximately ₹829.
Piramal Pharma Ltd. Share Price Target 2030 : Long term projections for 2030 range from ₹894 to ₹964 with an average target of ₹929.
Piramal Pharma Ltd. Share Price Target 2040 : The stock could be potentially be in the range of ₹1,788 to ₹1,928 depending on the market conditions, inflation, and the company’s performance.
Piramal Pharma Ltd. Share Price Target 2050 : With continued growth, the stock could theoretically reach ₹2,356 to ₹3,856 or more, but this is highly speculative and assumes that the company continues to perform well over long term.
For more detailed projections and updates, it is advisable to keep track of market reports and financial news.
About The Company
Piramal Pharma Ltd. was founded on March 4, 2020 in Mumbai, India. It develops and manufactures pharmaceuticals, including skincare, vitamins, nutrition, analgesics, and baby care products. The company has a significant presence in global markets and offers contract development and manufacturing services all over the world. Visit piramalpharmasolutions.com for more info.
Fundamentals Of The Company
| Market Cap | ₹28,232 Cr |
| PE Ratio(TTM) | 1014.05 |
| P/B Ratio | 3.57 |
| Industry P/E | 38.98 |
| Debt to Equity | 0.60 |
| ROCE | 5.49% |
| ROE | 0.20% |
| Div Yield | 0.05% |
| Book Value | ₹59.70 |
| Face Value | 10 |
| EPS(TTM) | 0.21 |
- Market Cap : The market capitalization of Piramal Pharma Ltd. is ₹28,232 crore. This figure represents the total market value of the company’s outstanding shares and indicates its size and significance in the stock market.
- P/E Ratio : The Price to Earning (P/E) Ratio for Piramal Pharma Ltd. based on trailing twelve months(TTM) data is 1014.05. This ratio indicates how much investors are willing to pay per rupee of earnings, reflecting market expectations of the company’s future growth prospects.
- P/B Ratio : The Price to Book Ratio for Piramal Pharma Ltd. is 3.57. This ratio compares the company’s market capitalization to its book value, providing insight into how much investors are willing to pay for each rupee of net assets.
- Industry P/E : The Industry P/E Ratio is 38.98. This figure represents the average P/E Ratio for companies within the same industry, providing a benchmark for comparing Piramal Pharma Ltd.’s valuation to its peers.
- Debt to Equity : The Debt to Equity for Piramal Pharma Ltd. is 0.60. This indicates that the company has relatively low levels of debt compared to its equity, suggesting a conservative approach to leveraging.
- ROE : The Return on Equity for Piramal Pharma Ltd. is 0.20%. This metric measures the company,s profitability relative to shareholder’s equity, indicating how effectively it is using shareholder’s funds to generate profit.
- EPS : The Earnings Per Share for Piramal Pharma Ltd. is 0.21. This figure represents the portion of a company’s profit allocated to each outstanding share of common stock, reflecting its profitability on a per-share basis.
- Div Yield : The Dividend Yield for Piramal Pharma Ltd. is 0.05%. This ratio indicates the percentage of the company’s share price that is paid out as dividends to shareholders annually.
- Book Value : The Book Value per Share for Piramal Pharma Ltd. is ₹59.70. This figure represents the value of the company’s net assets available to common shareholders, dividend by the number of outstanding shares.
- Face Value : The Face Value per Share for Piramal Pharma Ltd. is 10. This is the nominal value of each share as stated on the stock certificate and does not reflect the market value of the share.
Income statement
| Income Statement | |
|---|---|
| Basic EPS (FY) | 0.14 |
| Basic EPS (TTM) | 0.21 |
| EPS Diluted (FY) | 0.14 |
| Net Income (FY) | 178.20 M |
| EBITDA (TTM) | 12.68 B |
| Gross Profit (MRQ) | 5.13 B |
| Gross Profit (FY) | 16.78 B |
| Last Year Revenue (FY) | 8.71 B |
| Total Revenue (FY) | 8.71 B |
| Free Cash Flow (TTM) | _ |
Financial Ratio (Last 5 Years)
| Year | Operating Profit Margin | Net Profit Margin | Earning Per Share |
|---|---|---|---|
| 2021 | 26.25% | 13.22% | 13.30 |
| 2022 | 19.35% | 5.73% | 3.19 |
| 2023 | 12.72% | -2.63% | -1.54 |
| 2024 | 17.47% | 0.19% | 0.14 |
Shareholding Pattern
Gainers/Loosers
Penny Stocks To Buy Now
All About Indian Stock Market –Â BSE, NSE, SEBI, SENSEX, NIFTY 50
Disclaimer
The author and this blog do not assume any responsibility for any investment decisions made based on the information provided. Always exercise and due diligence when investing.
